IMVT Kronos AI forecast
A 30-trading-day price forecast for Immunovant Inc. (IMVT) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Immunovant Inc. at $34.34 on 2026-12-08, +18.9% from the last close of $28.88 on 2026-10-27. Eight out of ten sampled paths end between $33.89 and $36.49, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of IMVT
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $28.68 | $28.40 | $29.97 |
| 2026-11-10 | $29.81 | $28.93 | $33.43 |
| 2026-11-17 | $32.51 | $30.50 | $34.81 |
| 2026-11-24 | $33.33 | $29.86 | $34.91 |
| 2026-12-01 | $33.51 | $32.30 | $34.54 |
| 2026-12-08 | $34.34 | $33.89 | $36.49 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for IMVT?
- Kronos AI's median forecast for IMVT is $34.34 in 30 trading days, +18.9% from the last close, with a 10–90% range of $33.89 to $36.49.
- Is the IMVT Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.